Last data update: Dec 12, 2019. (Total: 2724 publications since 2011)
|Query Trace: Newborn screening[orginal query]|
| Ensuring the Life-Span Benefits of Newborn Screening.
Alex R Kemper, Coleen A Boyle, Jeffrey P Brosco, and Scott D Grosse
Pediatrics 2019 Nov
| Using Decision Analysis to Support Newborn Screening Policy Decisions: A Case Study for Pompe Disease.
Lisa A Prosser, K K Lam, Scott D Grosse, Mia Casale, and Alex R Kemper
MDM policy & practice 3(1)
| Primary Care Provider Management of Congenital Hypothyroidism Identified Through Newborn Screening.
N A Rosenthal, E Bezar, S Mann, L K Bachrach, S Banerjee, M E Geffner, M Gottschalk, S K Shapira, L Hasegawa, and L Feuchtbaum
Annals of thyroid research 2017 3(1) 95-101
| Liquid Chromatography-Tandem Mass Spectrometry Assay of Leukocyte Acid a-Glucosidase for Post-Newborn Screening Evaluation of Pompe Disease.
Na Lin, Jingyu Huang, Sara Violante, Joseph J Orsini, Michele Caggana, Erin E Hughes, Colleen Stevens, Lisa DiAntonio, Hsuan Chieh Liao, Xinying Hong, Farideh Ghomashchi, Arun Babu Kumar, Hui Zhou, Ruth Kornreich, Melissa Wasserstein, Michael H Gelb, and Chunli Yu
Clinical chemistry 2017 Feb
| Newborn screening for X-linked adrenoleukodystrophy: evidence summary and advisory committee recommendation.
Alex R Kemper, Jeffrey Brosco, Anne Marie Comeau, Nancy S Green, Scott D Grosse, Elizabeth Jones, Jennifer M Kwon, Wendy K K Lam, Jelili Ojodu, Lisa A Prosser, and Susan Tanksley
Genetics in medicine : official journal of the American College of Medical Genetics 2017 19(1) 121-126
| A framework for assessing outcomes from newborn screening: on the road to measuring its promise.
Cynthia F Hinton, Charles J Homer, Alexis A Thompson, Andrea Williams, Kathryn L Hassell, Lisa Feuchtbaum, Susan A Berry, Anne Marie Comeau, Bradford L Therrell, Amy Brower, Katharine B Harris, Christine Brown, Jana Monaco, Robert J Ostrander, Alan E Zuckerman, Celia Kaye, Denise Dougherty, Carol Greene, Nancy S Green, and
Molecular genetics and metabolism 2016 May
| The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience.
Scott D Grosse, John D Thompson, Yao Ding, and Michael Glass
The Milbank quarterly 2016 94(2) 366-91
| Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State.
Yao Ding, John D Thompson, Lisa Kobrynski, Jelili Ojodu, Guisou Zarbalian, and Scott D Grosse
The Journal of pediatrics 2016 Feb
| The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.
Maria D Karaceper, Pranesh Chakraborty, Doug Coyle, Kumanan Wilson, Jonathan B Kronick, Steven Hawken, Christine Davies, Marni Brownell, Linda Dodds, Annette Feigenbaum, Deshayne B Fell, Scott D Grosse, Astrid Guttmann, Anne-Marie Laberge, Aizeddin Mhanni, Fiona A Miller, John J Mitchell, Meranda Nakhla, Chitra Prasad, Cheryl Rockman-Greenberg, Rebecca Sparkes, Brenda J Wilson, Beth K Potter, and
Orphanet journal of rare diseases 2016 Feb 1112
| Showing Value in Newborn Screening: Challenges in Quantifying the Effectiveness and Cost-Effectiveness of Early Detection of Phenylketonuria and Cystic Fibrosis.
Scott D Grosse
Healthcare (Basel, Switzerland) 2015 3(4) 1133-57
| Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium.
Frédéric B Piel, Thomas V Adamkiewicz, Djesika Amendah, Thomas N Williams, Sunetra Gupta, and Scott D Grosse
Genetics in medicine : official journal of the American College of Medical Genetics 2015 Dec
| Representativeness of Tuberculosis Genotyping Surveillance in the United States, 2009-2010.
Emma B Shak, Anne Marie France, Lauren Cowan, Angela M Starks, and Juliana Grant
Public health reports (Washington, D.C. : 1974) 130(6) 596-601
| A Cost-Effectiveness Analysis of a Pilot Neonatal Screening Program for Sickle Cell Anemia in the Republic of Angola.
Patrick T McGann, Scott D Grosse, Brigida Santos, Vysolela de Oliveira, Luis Bernardino, Nicholas J Kassebaum, Russell E Ware, and Gladstone E Airewele
The Journal of pediatrics 2015 Dec 167(6) 1314-9
| Simultaneous quantitation of hexacosanoyl lysophosphatidylcholine, amino acids, acylcarnitines, and succinylacetone during FIA-ESI-MS/MS analysis of dried blood spot extracts for newborn screening.
Christopher A Haynes, and Víctor R De Jesús
Clinical biochemistry 2015 Oct
| Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.
Patrice K Held, Stuart K Shapira, Cynthia F Hinton, Elizabeth Jones, W Harry Hannon, and Jelili Ojodu
Mol. Genet. Metab. 2015 Aug 12.
| Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.
Richard S Olney, Elizabeth C Ailes, and Marci K Sontag
Semin. Perinatol. 2015 Apr 39(3) 230-7
| Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States.
Cara T Mai, Russell S Kirby, Adolfo Correa, Deborah Rosenberg, Michael Petros, and Michael C Fagen
Journal of public health management and practice : JPHMP 22(3) E1-8
| Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study.
Mei W Baker, Anne E Atkins, Suzanne K Cordovado, Miyono Hendrix, Marie C Earley, and Philip M Farrell
Genet. Med. 2015 Feb 12.
| Incidence of sickle cell trait--United States, 2010.
Jelili Ojodu, Mary M Hulihan, Shammara N Pope, Althea M Grant, and
MMWR Morb. Mortal. Wkly. Rep. 2014 Dec 12. 63(49) 1155-8
| Universal state newborn screening programs can reduce health disparities.
Jeffrey P Brosco, Scott D Grosse, and Lainie Friedman Ross
JAMA Pediatr 2015 Jan 169(1) 7-8
| The stability of hexacosanoyl lysophosphatidylcholine in dried-blood spot quality control materials for X-linked adrenoleukodystrophy newborn screening.
Christopher A Haynes, and Víctor R De Jesús
Clin. Biochem. 2015 Jan 48(1-2) 8-10
| Mortality of New York children with sickle cell disease identified through newborn screening.
Ying Wang, Gang Liu, Michele Caggana, Joseph Kennedy, Regina Zimmerman, Suzette O Oyeku, Ellen M Werner, Althea M Grant, Nancy S Green, and Scott D Grosse
Genet. Med. 2015 Jun 17(6) 452-9
| Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.
Víctor R De Jesús, Barbara W Adam, Daniel Mandel, Carla D Cuthbert, and Dietrich Matern
Mol. Genet. Metab. 113(1-2) 67-75
| Reflections on 50 years of newborn screening.
Coleen A Boyle, Joseph A Bocchini, and James Kelly
Pediatrics 2014 Jun 133(6) 961-3
| A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
Cora Peterson, Scott D Grosse, Jill Glidewell, Lorraine F Garg, Kim Van Naarden Braun, Mary M Knapp, Leslie M Beres, Cynthia F Hinton, Richard S Olney, and Cynthia H Cassell
Public Health Rep 129(1) 86-93
| Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.
Cynthia F Hinton, Cara T Mai, Sarah K Nabukera, Lorenzo D Botto, Lisa Feuchtbaum, Paul A Romitti, Ying Wang, Kimberly Noble Piper, and Richard S Olney
Genet. Med. 2014 Jun 16(6) 484-90
| Newborn screening: from Guthrie to whole genome sequencing.
Michele Caggana, Elizabeth A Jones, S I Shahied, Susan Tanksley, Cheryl A Hermerath, and Ira M Lubin
Public Health Rep 128 Suppl 214-9
| Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs.
Richard S Olney, and Lorenzo D Botto
Birth Defects Res. Part A Clin. Mol. Teratol. 2012 Dec 94(12) 965-9
| Public health action in genomics is now needed beyond newborn screening.
M S Bowen, K Kolor, W D Dotson, R M Ned, and M J Khoury
Public health genomics 2012 15(6) 327-34
| Improving newborn screening follow-up in pediatric practices: quality improvement innovation network.
Cynthia F Hinton, Daniel R Neuspiel, Ruth S Gubernick, Timothy Geleske, Jill Healy, Alex R Kemper, Michele A Lloyd-Puryear, Robert A Saul, Barry H Thompson, and Celia I Kaye
Pediatrics 2012 Sep 130(3) e669-75
| CDC Grand Rounds: Newborn screening and improved outcomes.
MMWR. Morbidity and mortality weekly report 2012 Jun 61(21) 390-3
| Improved analysis of C26:0-lysophosphatidylcholine in dried-blood spots via negative ion mode HPLC-ESI-MS/MS for X-linked adrenoleukodystrophy newborn screening.
Christopher A Haynes, and Víctor R De Jesús
Clin. Chim. Acta 2012 Aug 16. 413(15-16) 1217-21
| Decision analysis, economic evaluation, and newborn screening: challenges and opportunities.
Lisa A Prosser, Scott D Grosse, Alex R Kemper, Beth A Tarini, and James M Perrin
Genet. Med. 2012 Apr 5.
| Evidence-based path to newborn screening for Duchenne muscular dystrophy.
Jerry R Mendell, Chris Shilling, Nancy D Leslie, Kevin M Flanigan, Roula al-Dahhak, Julie Gastier-Foster, Kelley Kneile, Diane M Dunn, Brett Duval, Alexander Aoyagi, Cindy Hamil, Maha Mahmoud, Kandice Roush, Lauren Bird, Chelsea Rankin, Heather Lilly, Natalie Street, Ram Chandrasekar, and Robert B Weiss
Ann. Neurol. 2012 Mar 71(3) 304-13
| Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.
Thomas P Mechtler, Susanne Stary, Thomas F Metz, Víctor R De Jesús, Susanne Greber-Platzer, Arnold Pollak, Kurt R Herkner, Berthold Streubel, and David C Kasper
Lancet 2012 Jan 28. 379(9813) 335-41
| The role of health technology assessment in coverage decisions on newborn screening.
Katharina E Fischer, Scott D Grosse, and Wolf H Rogowski
International journal of technology assessment in health care 2011 Oct 27(4) 313-21
| The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States.
B W Adam, E M Hall, M Sternberg, T H Lim, S R Flores, S O'Brien, D Simms, L X Li, V R De Jesus, and W H Hannon
Clin. Biochem. 2011 Dec 44(17-18) 1445-50
| Ethical implications and practical considerations of ethnically targeted screening for genetic disorders: the case of hemoglobinopathy screening.
Cynthia F Hinton, Althea M Grant, and Scott D Grosse
Ethn Health 16(4-5) 377-88
| What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.
Cynthia F Hinton, Lisa Feuchtbaum, Christopher A Kus, Alex R Kemper, Susan A Berry, Jill Levy-Fisch, Julie Luedtke, Celia Kaye, and Coleen A Boyle
Genet. Med. 2011 Oct 13(10) 861-5
| Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States.
Vicki S Hertzberg, Cynthia F Hinton, Bradford L Therrell, and Stuart K Shapira
J. Pediatr. 2011 Oct 159(4) 555-60
| The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.
William A Hagopian, Henry Erlich, Ake Lernmark, Marian Rewers, Anette G Ziegler, Olli Simell, Beena Akolkar, Robert Vogt, Alan Blair, Jorma Ilonen, Jeffrey Krischer, JinXiong She, and
Pediatr Diabetes 2011 Dec 12(8) 733-43
| Newborn bloodspot screening for lysosomal storage disorders.
Hui Zhou, Paul Fernhoff, and Robert F Vogt
J. Pediatr. 2011 Jul 159(1) 7-13.e1
| Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.
Steven J Korzeniewski, William I Young, Harry C Hawkins, Kevin Cavanagh, Samya Z Nasr, Carrie Langbo, Kelly R Teneyck, Scott D Grosse, Mary Kleyn, and Violanda Grigorescu
Pediatric pulmonology 2011 Feb 46(2) 125-30